Webinars Archives - Sona Nanotech

Webinars

Investor Webinar Update 20 October 2025

October 20, 2025

Webinars

Investor Webinar Update July 16th

July 14, 2025

Webinars

Investor Webinar Ahead of First-in-Human Clinical Trial

May 16, 2025

Webinars

A Novel Immunotherapy Device Priming the Immune System to Enable Immunotherapy

March 26, 2025

Webinars

Colorectal Cancer Preclinical Study Results – Webinar Dec. 11th 2024

December 11, 2024

Webinars

Join Sona Nanotech’s CEO, David Regan, and CMO, Dr. Carman Giacomantonio, December 11th 2024

December 10, 2024

Webinars

CanAm Melanoma Treatment Efficacy Study Discussion

July 11, 2024

Webinars

Webinar Update January 25th, 2024 Hosted by David Regan & Len Pagliaro PhD

January 31, 2024

Webinars

Webinar Oct 25th 2023 Update Hosted by CEO David Regan & CSO Len Pagliaro PhD

October 25, 2023

Webinars

Webinar Sept 20th 2023 with Dr Carman Giacomantonio MD, MSc., FRCSC & Barry Kennedy, PhD

September 20, 2023

Webinars

Live Webinar Sept 20th, 2pm EST With Dr Carman Giacomantonio, MD, MSc., FRCSC

September 14, 2023

Webinars

Live Webinar 25 Oct, 2pm EST Hosted by David Regan & Len Pagliaro PhD

September 14, 2023

Webinars

Webinar Sept 7th 2023 Update Hosted by David Regan & Len Pagliaro PhD

September 7, 2023

Webinars

Webinar Aug 03, 2023 Webinar Update by David Regan & Len Pagliaro PhD

August 3, 2023

Webinars

June 8th 1pm EDT Webinar Hosted by CEO David Regan & CSO Len Pagliaro PhD

June 15, 2023

Webinars

Webinar Update June 8th 1pm EDT Hosted by CEO David Regan & CSO Len Pagliaro PhD

June 6, 2023

Webinars

What is Ablation in Targeted Hyperthermia Therapy™ (THT) ? – Mar 2023 Webinar Extract

April 12, 2023

Webinars

Sona at a Glance – Mar 2023 Webinar Extract

April 12, 2023

Webinars

Pre-Clinical Targeted Hyperthermia Therapy TM success data from small animal studies explained.

April 5, 2023

Webinars

Sona Nanotech and Siva Therapeutics transaction – Mar 2023 Webinar Extract

March 30, 2023

Webinars

Targeted Hyperthermia Therapy™ (THT) – Mar 2023 Webinar Extract

March 30, 2023

Category: Webinars

Investor Webinar Update 20 October 2025

Investor Webinar Update July 16th

Investor Webinar Ahead of First-in-Human Clinical Trial

A Novel Immunotherapy Device Priming the Immune System to Enable Immunotherapy

Colorectal Cancer Preclinical Study Results – Webinar Dec. 11th 2024

Join Sona Nanotech’s CEO, David Regan, and CMO, Dr. Carman Giacomantonio, December 11th 2024

CanAm Melanoma Treatment Efficacy Study Discussion

Webinar Update January 25th, 2024 Hosted by David Regan & Len Pagliaro PhD

Webinar Oct 25th 2023 Update Hosted by CEO David Regan & CSO Len Pagliaro PhD

Webinar Sept 20th 2023 with Dr Carman Giacomantonio MD, MSc., FRCSC & Barry Kennedy, PhD

Live Webinar Sept 20th, 2pm EST With Dr Carman Giacomantonio, MD, MSc., FRCSC

Live Webinar 25 Oct, 2pm EST Hosted by David Regan & Len Pagliaro PhD

Webinar Sept 7th 2023 Update Hosted by David Regan & Len Pagliaro PhD

Webinar Aug 03, 2023 Webinar Update by David Regan & Len Pagliaro PhD

June 8th 1pm EDT Webinar Hosted by CEO David Regan & CSO Len Pagliaro PhD

Webinar Update June 8th 1pm EDT Hosted by CEO David Regan & CSO Len Pagliaro PhD

What is Ablation in Targeted Hyperthermia Therapy™ (THT) ? – Mar 2023 Webinar Extract

Sona at a Glance – Mar 2023 Webinar Extract

Pre-Clinical Targeted Hyperthermia Therapy TM success data from small animal studies explained.

Sona Nanotech and Siva Therapeutics transaction – Mar 2023 Webinar Extract

Targeted Hyperthermia Therapy™ (THT) – Mar 2023 Webinar Extract

Subscribe to Our Newsletter

Download the Company Presentation

Read in Frontiers in Immunology our Published Research

Technology

Therapies

Diagnostics

Investors

Store

News & Media

About Us

Contact Us

Follow Us